3-Bromopyruvate Attenuates Experimental Pulmonary Hypertension via Inhibition of Glycolysis

Yun‐Long Zhang, Rui Zhang, Yifan Shen, Kai-Yue Huang, Yangyang He, Junhan Zhao, Zhi‐Cheng JingAmerican 2018 · DOI

Abstract

This study demonstrates the reversal of PH by 3-BrPA is related to alteration in glycolysis and improved mitochondria function, indicating the "metabolic targeting" as a rational therapeutic strategy for PH.
BibTeX
@inproceedings{zhang2018bromopyruvate,
  author = {Yun‐Long Zhang and Rui Zhang and Yifan Shen and Kai-Yue Huang and Yangyang He and Junhan Zhao and Zhi‐Cheng Jing},
  title = {{3-Bromopyruvate Attenuates Experimental Pulmonary Hypertension <i>via</i> Inhibition of Glycolysis}},
  booktitle = {American},
  year = {2018},
  doi = {10.1093/ajh/hpy191},
}

Loading related content...

Figure